ºÚÁϲ»´òìÈ researcher Dr. John Lewis granted $4.2 million CIHR grant.

Su-Ling Goh and Alex Antoneshyn - 25 June 2020

A COVID-19 vaccine developed in Edmonton is moving forward to human trials this summer.

Entos Pharmaceuticals, led by ºÚÁϲ»´òìÈ researcher Dr. John Lewis, has selected two promising vaccine prototypes to start testing in people.

"We have two really excellent candidates that produce a very strong neutralizing antibody immune response [in animals]," Lewis told Global News.

The Government of Canada has granted Lewis $4.2 million to take the project to the next step, part of the , which awarded $109 million to 139 research teams across the country this month.

Made-in-ºÚÁϲ»´òìÈ COVID-19 vaccine prototypes to be tested on humans by Alex Antoneshyn, CTV News Edmonton